Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026)
Bright Minds Biosciences (DRUG) posted Exchange Rate Effect of $1.0 million for Q1 2026, up 200.82% on a QoQ basis from -$1.0 million in Q4 2025, and up 8938.63% year-over-year from $11483.2 in Q1 2025.
Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Bright Minds Biosciences' Exchange Rate Effect history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Exchange Rate Effect rose 8938.63% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$932823.2 (down 177.98% YoY) and the FY2025 annual result came in at $227164.3, up 2544.09% from the prior year.
- Exchange Rate Effect was $1.0 million for Q1 2026 at Bright Minds Biosciences, up from -$1.0 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.2 million in Q4 2024 and bottomed at -$1.0 million in Q4 2025.
- A 5-year average of $14624.7 and a median of $3943.3 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect slumped 3263.82% — and 2026, when it jumped 8938.63%.
- Bright Minds Biosciences' Exchange Rate Effect stood at $5193.0 in 2022, then slumped by 698.25% to -$31067.2 in 2023, then soared by 3855.98% to $1.2 million in 2024, then sank by 188.23% to -$1.0 million in 2025, then soared by 200.82% to $1.0 million in 2026.
- Business Quant data shows DRUG's Exchange Rate Effect at $1.0 million in Q1 2026, -$1.0 million in Q4 2025, and -$384416.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -384,416.08 |
| Sep 30, 2025 | -384,416.08 |
| Jun 30, 2025 | -556,838.00 |
| Jun 30, 2025 | -556,838.00 |
| Mar 31, 2025 | -11,743.04 |
| Mar 31, 2025 | -11,743.04 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 12,150.36 |
| Sep 30, 2024 | 12,150.36 |
| Jun 30, 2024 | 28,956.82 |
| Jun 30, 2024 | 28,956.82 |
| Mar 31, 2024 | -1,606.68 |
| Mar 31, 2024 | -1,606.68 |
| Dec 31, 2023 | -31,067.18 |
| Dec 31, 2023 | -31,067.18 |